Since over 60% of the ME/CFS cohort reported an infectious trigger (Table 1), we expanded the previous characterization of NK cells in ME/CFS cases and healthy controls by analyzing the potential biomarker value of the CD57 expression with NKp46 or NKG2C. This evidence concerns the gene B3GAT1 and myalgic encephalomeyelitis/chronic fatigue syndrome.